Alix E Seif, Brian T Fisher, Yimei Li, Kari Torp, Douglas P Rheam, Yuan-Shung V Huang, Tracey Harris, Ami Shah, Matthew Hall, Evan S Fieldston, Marko Kavcic, Marijana Vujkovic, L Charles Bailey, Leslie S Kersun, Anne F Reilly, Susan R Rheingold, Dana M Walker, Richard Aplenc
BACKGROUND: Deaths during induction chemotherapy for pediatric acute lymphoblastic leukemia (ALL) account for one-tenth of ALL-associated mortality and half of ALL treatment-related mortality. We sought to ascertain patient- and hospital-level factors associated with induction mortality. PROCEDURE: We performed a retrospective cohort analysis of 8,516 children ages 0 to <19 years with newly diagnosed ALL admitted to freestanding US children's hospitals from 1999 to 2009 using the Pediatric Health Information System database...
May 2014: Pediatric Blood & Cancer